Galaxa Pharma a/s — Credit Rating and Financial Key Figures
CVR number: 41183144
Indiakaj 10, 2100 København Ø
info@galaxapharma.com
tel: 27742280
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
External services | -6.12 | ||||
Gross profit | -6.12 | -6.03 | - 845.55 | -1 971.40 | - 898.06 |
Employee benefit expenses | - 193.60 | -1 601.96 | -12.82 | -1.55 | |
Total depreciation | - 113.33 | - 113.33 | - 113.33 | ||
EBIT | -6.12 | - 199.63 | -2 560.85 | -2 071.91 | -1 012.95 |
Other financial income | 7.14 | -0.44 | 0.03 | ||
Other financial expenses | -2.23 | - 150.50 | -76.44 | -71.29 | |
Pre-tax profit | -6.12 | - 201.86 | -2 704.21 | -2 148.80 | -1 084.21 |
Income taxes | 68.20 | 658.37 | 405.94 | 264.40 | |
Net earnings | -6.12 | - 133.66 | -2 045.84 | -1 742.86 | - 819.81 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Development expenditure | 340.00 | 230.93 | 117.60 | 5.63 | |
Intangible assets total | 340.00 | 230.93 | 117.60 | 5.63 | |
Tangible assets total | |||||
Investments total | 26.83 | 22.40 | |||
Long term receivables total | |||||
Finished products/goods | 1 530.39 | 725.08 | 225.90 | 127.10 | |
Inventories total | 1 530.39 | 725.08 | 225.90 | 127.10 | |
Current trade debtors | 112.51 | 53.30 | 17.52 | 6.03 | |
Current amounts owed by group member comp. | 500.00 | 1 052.23 | 896.79 | 4.27 | |
Current other receivables | 519.11 | 163.45 | 44.48 | ||
Current deferred tax assets | 68.20 | 726.57 | 1 132.51 | 1 396.91 | |
Short term receivables total | 500.00 | 699.82 | 1 832.11 | 2 210.26 | 1 451.69 |
Cash and bank deposits | 0.01 | 809.97 | 259.24 | 7.83 | 13.93 |
Cash and cash equivalents | 0.01 | 809.97 | 259.24 | 7.83 | 13.93 |
Balance sheet total (assets) | 500.01 | 3 380.18 | 3 074.18 | 2 583.98 | 1 598.35 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 1 000.00 |
Other reserves | 265.20 | 180.13 | 91.72 | 4.39 | |
Retained earnings | - 271.31 | 2 180.10 | 1 722.66 | 67.13 | |
Profit of the financial year | -6.12 | - 133.66 | -2 045.84 | -1 742.86 | - 819.81 |
Shareholders equity total | 493.88 | 360.23 | 814.38 | 571.52 | 251.71 |
Non-current owed to group member | 1.12 | ||||
Non-current liabilities total | 1.12 | ||||
Current loans from credit institutions | 0.50 | 3.80 | |||
Current trade creditors | 5.00 | 674.14 | 700.35 | 680.90 | |
Current owed to group member | 2 986.18 | 1 267.61 | 1 295.31 | 652.74 | |
Other non-interest bearing current liabilities | 33.78 | 317.55 | 13.00 | 13.00 | |
Current liabilities total | 5.00 | 3 019.96 | 2 259.80 | 2 012.46 | 1 346.65 |
Balance sheet total (liabilities) | 500.01 | 3 380.18 | 3 074.18 | 2 583.98 | 1 598.35 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.